Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

Journal of immunology (Baltimore, Md. : 1950) - 1 Aug 2006

Knutson Keith L, Lu Hailing, Stone Brad, Reiman Jennifer M, Behrens Marshall D, Prosperi Christine M, Gad Ekram A, Smorlesi Arianna, Disis Mary L

Abstract excerpt

Tumors evade both natural and pharmacologically induced (e.g., vaccines) immunity by a variety of mechanisms, including induction of tolerance and immunoediting. Immunoediting results in reshaping the immunogenicity of the tumor, which can be accompanied by loss of Ag expression and MHC molecules. In this study, we evaluated immunoediting in the neu-transgenic mouse model of breast cancer. A tumor cell line that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4-Positive T-Lymphocytes
Share to Graft Rejection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Mammary Neoplasms, Experimental

Share to Mesoderm

Share to Neoplasm Transplantation

Share to Receptor, ErbB-2

Share to Tumor Escape

Source

Identifiers

PMID: 16849459
DOI: 10.4049/jimmunol.177.3.1526

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunoediting of cancers may lead to epithelial to mesenchymal transition.PMID 16849459Read ↗

Cancer immunoediting: from immunosurveillance to tumor escape.Semantic proximity Read ↗

From mice to humans: developments in cancer immunoeditingSemantic proximity Read ↗

Epithelial-to-mesenchymal transition in cancer progression: unraveling the immunosuppressive module driving therapy resistance.Semantic proximity Read ↗

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.Semantic proximity Read ↗

Innate Cancer Immunoediting.Semantic proximity Read ↗

Immunological Consequences of Epithelial–Mesenchymal Transition in Tumor ProgressionSemantic proximity Read ↗

The Three Es of Cancer ImmunoeditingSemantic proximity Read ↗

Expression of tumour-specific antigens underlies cancer immunoediting.Semantic proximity Read ↗

Tumor plasticity interferes with anti-tumor immunity.Semantic proximity Read ↗

CD4 <sup>+</sup> T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapySemantic proximity Read ↗

Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironmentSemantic proximity Read ↗

The evolving understanding of immunoediting and the clinical impact of immune escapeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.